Selecting the Optimal In Vivo Platform for Oncology Drug Development
Developing therapeutics for cancer can be a time- and cost-intensive process. An investigational new drug application can take anywhere from 3-6 years and it is twice as long and more than double the effort to apply for market approval; therefore, choosing the wrong model can have long-term consequences. This makes it even more important for researchers to find the right one for their specific mode of action, modality, and tumor entity at a specific time point.
Join this webinar and learn about:
- The drug development process
- PDX and mouse tumor model case studies
- Selecting optimal in vivo mouse & rat model platforms
Webinar presenter: Julia Schueler, DVM, PhD
Research Director, Therapeutic Area Lead Charles River